New injection trial targets rare blood cancer symptoms
NCT ID NCT05467800
Summary
This study is testing whether canakinumab, an anti-inflammatory injection given every 3 weeks, can help control myelofibrosis. Researchers want to see if it reduces symptoms like fatigue and enlarged spleen, improves anemia, and is safe for patients. The trial is for adults with myelofibrosis who have specific symptoms and may or may not be on other standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Atrium Health Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
NOT_YET_RECRUITINGLos Angeles, California, 90048, United States
Contact
-
Cleveland Clinic Foundation
NOT_YET_RECRUITINGCleveland, Ohio, 44195, United States
Contact
-
Mayo Clinic Arizona
WITHDRAWNPhoenix, Arizona, 85259, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
-
Ruttenberg Treatment Center
RECRUITINGNew York, New York, 10029, United States
-
The University of Kansas Cancer Center-Westwood
RECRUITINGWestwood, Kansas, 66205, United States
Contact
-
Wake Forest Baptist Health Comprehensive Cancer Center
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact
Conditions
Explore the condition pages connected to this study.